WO2011105821A3 - 무혈청 줄기 세포 배양 조성물, 이를 함유한 조직 재생용 조성물 및 이를 이용한 조직 재생 방법 - Google Patents

무혈청 줄기 세포 배양 조성물, 이를 함유한 조직 재생용 조성물 및 이를 이용한 조직 재생 방법 Download PDF

Info

Publication number
WO2011105821A3
WO2011105821A3 PCT/KR2011/001282 KR2011001282W WO2011105821A3 WO 2011105821 A3 WO2011105821 A3 WO 2011105821A3 KR 2011001282 W KR2011001282 W KR 2011001282W WO 2011105821 A3 WO2011105821 A3 WO 2011105821A3
Authority
WO
WIPO (PCT)
Prior art keywords
tissue regeneration
same
composition
serum
cell culture
Prior art date
Application number
PCT/KR2011/001282
Other languages
English (en)
French (fr)
Other versions
WO2011105821A2 (ko
Inventor
이순례
박현숙
김경혜
강태훈
Original Assignee
주식회사 아크스템
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 아크스템 filed Critical 주식회사 아크스템
Publication of WO2011105821A2 publication Critical patent/WO2011105821A2/ko
Publication of WO2011105821A3 publication Critical patent/WO2011105821A3/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/99—Serum-free medium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

본 발명은 개체의 피부, 연부 조직의 미용적 또는 퇴행적 결함을 교정하기 위한 무혈청 줄기 세포 배양 조성물 및 이를 함유한 조직 재생용 조성물에 관한 것이다. 보다 상세하게는 인간 지방 유래 줄기세포를 무혈청 줄기 세포 배양 조성물에서 배양한 배양액을 함유하는 조직 재생용 조성물 및 이를 이용한 조직 재생 방법에 관한 것이다.
PCT/KR2011/001282 2010-02-24 2011-02-24 무혈청 줄기 세포 배양 조성물, 이를 함유한 조직 재생용 조성물 및 이를 이용한 조직 재생 방법 WO2011105821A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020100016692A KR20110097064A (ko) 2010-02-24 2010-02-24 무혈청 줄기 세포 배양 조성물, 이를 함유한 조직 재생용 조성물 및 이를 이용한 조직 재생 방법
KR10-2010-0016692 2010-02-24

Publications (2)

Publication Number Publication Date
WO2011105821A2 WO2011105821A2 (ko) 2011-09-01
WO2011105821A3 true WO2011105821A3 (ko) 2012-01-12

Family

ID=44507437

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/001282 WO2011105821A2 (ko) 2010-02-24 2011-02-24 무혈청 줄기 세포 배양 조성물, 이를 함유한 조직 재생용 조성물 및 이를 이용한 조직 재생 방법

Country Status (2)

Country Link
KR (1) KR20110097064A (ko)
WO (1) WO2011105821A2 (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013129885A1 (ko) * 2012-02-28 2013-09-06 건국대학교 산학협력단 세포 배양액
KR101863344B1 (ko) * 2016-07-15 2018-06-01 주식회사 엔바이오텍 줄기세포의 무혈청 배양액을 유효성분으로 함유하는 피부 항노화용 화장료 조성물
KR101877793B1 (ko) * 2016-07-15 2018-07-13 주식회사 엔바이오텍 줄기세포 배양용 무혈청 배지 조성물 및 이를 이용한 줄기세포의 배양 방법
KR102144593B1 (ko) * 2017-06-07 2020-08-13 주식회사 엑소스템텍 인간줄기세포 유래 엑소좀을 포함하는 세포 배양용 무혈청 배지 조성물
KR20190060716A (ko) * 2017-11-24 2019-06-03 주식회사 차바이오랩 무혈청 배지 조성물
KR102121602B1 (ko) * 2018-06-27 2020-06-10 주식회사 티아라줄기세포연구소 지방줄기세포배양용 배지 조성물 제조방법, 지방줄기세포배양용 배지 조성물 제조방법과 줄기세포 유효성분 3저 추출법을 이용한 줄기세포파쇄추출물(쉘드줄기세포) 제조방법, 이를 이용한 항관절염 치료용 조성물, 이를 이용한 염증억제 효과를 갖는 조성물 및 세포재생 효과를 갖는 조성물
KR102136172B1 (ko) 2019-09-25 2020-08-27 주식회사 다산씨엔텍 세포성장조절 단백질을 포함하는 인간줄기세포 배양액의 제조방법

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040082068A (ko) * 2003-03-18 2004-09-24 (주)안트로젠 동종 이식에 사용하기 위한 분화된 지방 세포
US7118746B1 (en) * 1999-05-14 2006-10-10 Skinmedica, Inc. Conditioned cell culture medium compositions and methods of use
KR100883565B1 (ko) * 2007-02-14 2009-02-13 (주)프로스테믹스 지방 줄기세포의 조직 재생 능력을 최적화한 조건 배지를 함유한 조직 재생용 주사제 첨가제

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118746B1 (en) * 1999-05-14 2006-10-10 Skinmedica, Inc. Conditioned cell culture medium compositions and methods of use
KR20040082068A (ko) * 2003-03-18 2004-09-24 (주)안트로젠 동종 이식에 사용하기 위한 분화된 지방 세포
KR100883565B1 (ko) * 2007-02-14 2009-02-13 (주)프로스테믹스 지방 줄기세포의 조직 재생 능력을 최적화한 조건 배지를 함유한 조직 재생용 주사제 첨가제

Also Published As

Publication number Publication date
KR20110097064A (ko) 2011-08-31
WO2011105821A2 (ko) 2011-09-01

Similar Documents

Publication Publication Date Title
IL273159A (en) A culture medium preparation, and a method for culturing cells or tissues by using the preparation
WO2011105821A3 (ko) 무혈청 줄기 세포 배양 조성물, 이를 함유한 조직 재생용 조성물 및 이를 이용한 조직 재생 방법
WO2010096588A3 (en) Cell culture media containing combinations of proteins
WO2008051568A3 (en) Methods and compositions for treatment of bone defects with placental cell populations
EP2048227A3 (en) Methods for proliferating stem cells
EP2639293A4 (en) CELL CULTURE CHAMBER, METHOD FOR PRODUCING THE SAME, FABRIC MODEL USING THE CELL CULTURE CHAMBER AND METHOD FOR PRODUCING THE SAME
WO2009151907A3 (en) Compositions and methods for using cells to treat heart tissue
HK1166100A1 (zh) 細胞、人工細胞構建體或三維複合組織裝配體的冷凍保存方法
WO2012142569A3 (en) Decellularized extracellular matrix
MX356756B (es) Células madre pluripotentes en microportadores.
GEP20146053B (en) Compounds expanding hematopoietic stem cells
EP2294183A4 (en) MESENCHYMAL STEM CELLS, COMPOSITIONS AND METHODS FOR TREATMENT OF CARDIAC TISSUE LESIONS
WO2012006426A3 (en) Regulatory polynucleotides and uses thereof
SG178914A1 (en) Stem cell conditioned medium compositions
WO2013070881A8 (en) Method for elimination of space through tissue approximation
WO2014053418A3 (en) Method for obtaining mesenchymal stem cells and use thereof
WO2011091350A3 (en) Methods & compositions for improving protein production
WO2013005110A3 (en) Synthetic scaffolds and organ and tissue transplantation
WO2011056017A3 (ko) 모낭 줄기세포의 대량 증식 방법
WO2012020100A3 (en) Compositions and methods for producing dendritic cells
WO2011099783A3 (ko) 지방조직 유래 줄기세포 및 단핵구로부터 세포성장인자의 생산방법 및 그 이용
WO2014027176A3 (en) Stem cell culture method
WO2012094255A3 (en) Decellularized liver transplantation composition and methods
WO2012119103A3 (en) Compositions and methods for mobilization of stem cells
EP2602310A4 (en) A SYSTEM FOR CULTURING CARRIER-CONTAINING BONE MARROW CELLS, A METHOD FOR CULTURING CARRIER-CONTAINING BONE MARROW CELLS, AND METHOD FOR PRODUCING A MEDICAL COMPOSITION USING CULTURED AUTOSERUM-CONTAINING BONE MARROW CELLS AS AN ACTIVE SUBSTANCE

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11747711

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11747711

Country of ref document: EP

Kind code of ref document: A2